Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis (HBV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02499562
Recruitment Status : Unknown
Verified May 2015 by Shanghai Genomics, Inc..
Recruitment status was:  Recruiting
First Posted : July 16, 2015
Last Update Posted : July 16, 2015
Information provided by (Responsible Party):
Shanghai Genomics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2017
Estimated Study Completion Date : July 2017